secwatch.observer — SEC 8-K summary
======================================

Issuer:     Natera, Inc. (NTRA)
CIK:        0001604821
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001104659-25-022968
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Natera appoints Monica Bertagnolli to Board of Directors
--------------------------------------------------------

- Board increased from 10 to 11; Bertagnolli appointed as Class III director, term expiring at 2027 annual meeting.
- She previously served from Nov 2020 to Aug 2022 before becoming Director of the National Cancer Institute.
- She is independent and appointed to Nominating, Corporate Governance and Compliance Committee.
- Compensation consistent with other non-employee directors; initial equity award vests over three years.
- Indemnification agreement entered into with Bertagnolli.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604821/000110465925022968/0001104659-25-022968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604821/000110465925022968/tm258931d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-022968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer